established an IL-17A gene knockout COPD–IPA mouse model and found that its Aspergillus fungal load was nearly twice that of the regular COPD–IPA mouse model, suggesting that IL-17 contributes to antifungal defense (87). This evidence concerns the gene IL17A and Ito hypomelanosis.